U.S. pharma huge copyright scrapped two experimental weight loss supplements past year—a after-daily pill, lotiglipron, because of elevated liver enzymes and also a twice-each day capsule, danuglipron, as a result of powerful Unwanted side effects—but CEO Albert Bourla has explained